
Praxis Precision Medicines Inc
NASDAQ:PRAX

Income Statement
Earnings Waterfall
Praxis Precision Medicines Inc
Revenue
|
8.6m
USD
|
Operating Expenses
|
-208.7m
USD
|
Operating Income
|
-200.2m
USD
|
Other Expenses
|
17.3m
USD
|
Net Income
|
-182.8m
USD
|
Income Statement
Praxis Precision Medicines Inc
Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
1
+114%
|
2
+32%
|
2
+27%
|
2
-10%
|
2
-19%
|
2
-9%
|
9
+433%
|
|
Operating Income | ||||||||||||||||||||
Operating Expenses |
(38)
|
(44)
|
(62)
|
(81)
|
(106)
|
(134)
|
(167)
|
(209)
|
(232)
|
(232)
|
(214)
|
(185)
|
(160)
|
(142)
|
(129)
|
(132)
|
(134)
|
(166)
|
(209)
|
|
Selling, General & Administrative |
(7)
|
(9)
|
(17)
|
(25)
|
(33)
|
(41)
|
(47)
|
(54)
|
(59)
|
(62)
|
(60)
|
(57)
|
(50)
|
(45)
|
(42)
|
(44)
|
(45)
|
(51)
|
(56)
|
|
Research & Development |
(31)
|
(34)
|
(45)
|
(56)
|
(73)
|
(93)
|
(120)
|
(155)
|
(172)
|
(170)
|
(154)
|
(127)
|
(110)
|
(97)
|
(87)
|
(88)
|
(90)
|
(115)
|
(152)
|
|
Operating Income |
(38)
N/A
|
(44)
-15%
|
(62)
-42%
|
(81)
-31%
|
(106)
-31%
|
(134)
-27%
|
(167)
-25%
|
(209)
-25%
|
(232)
-11%
|
(232)
0%
|
(214)
+8%
|
(184)
+14%
|
(159)
+14%
|
(140)
+12%
|
(126)
+10%
|
(130)
-3%
|
(133)
-2%
|
(164)
-24%
|
(200)
-22%
|
|
Pre-Tax Income | ||||||||||||||||||||
Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
3
|
5
|
9
|
13
|
17
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(38)
N/A
|
(44)
-15%
|
(62)
-42%
|
(81)
-31%
|
(106)
-31%
|
(134)
-27%
|
(167)
-25%
|
(208)
-25%
|
(232)
-11%
|
(231)
+0%
|
(214)
+8%
|
(183)
+15%
|
(157)
+14%
|
(138)
+12%
|
(123)
+10%
|
(125)
-2%
|
(124)
+1%
|
(151)
-22%
|
(183)
-21%
|
|
Net Income | ||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(38)
|
(44)
|
(62)
|
(81)
|
(106)
|
(134)
|
(167)
|
(208)
|
(232)
|
(231)
|
(214)
|
(183)
|
(157)
|
(138)
|
(123)
|
(125)
|
(124)
|
(151)
|
(183)
|
|
Net Income (Common) |
(44)
N/A
|
(53)
-19%
|
(70)
-33%
|
(88)
-25%
|
(111)
-26%
|
(135)
-22%
|
(167)
-24%
|
(208)
-25%
|
(232)
-11%
|
(231)
+0%
|
(214)
+8%
|
(183)
+15%
|
(157)
+14%
|
(138)
+12%
|
(123)
+10%
|
(125)
-2%
|
(124)
+1%
|
(151)
-22%
|
(183)
-21%
|
|
EPS (Diluted) |
-19.55
N/A
|
-20.68
-6%
|
-1.82
+91%
|
-34.23
-1 781%
|
-39.9
-17%
|
-45.32
-14%
|
-3.94
+91%
|
-68.76
-1 645%
|
-76.47
-11%
|
-75.83
+1%
|
-4.64
+94%
|
-51.62
-1 013%
|
-33.74
+35%
|
-15.21
+55%
|
-18.69
-23%
|
-9.01
+52%
|
-6.57
+27%
|
-7.99
-22%
|
-10.21
-28%
|